Researchers with the Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have received $5 million in funding from NCI to establish an HIV-associated Malignancy Research Center focused on lung cancer in East Africa.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
